Source:http://linkedlifedata.com/resource/pubmed/id/16258734
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-10-31
|
pubmed:abstractText |
Quorum sensing signal molecules (QSSMs) from the bacterium Pseudomonas aeruginosa control bacterial population density and the expression of virulence determinants. Coincidentally, and possibly to allow this pathogen to gain a foothold in the human body, certain signal molecules also downregulate immunological responses in an apparently T-helper 1-selective manner, which would suggest their application as therapeutics to some autoimmune diseases. In the present paper, experiments are described that indicate that one particular signal molecule, a synthetic N-(3-oxododecanoyl)-L-homoserine lactone, can be used to alleviate insulitis and diabetes in non-obese diabetic (NOD) mice, suggesting that bacterial signal molecules may represent a novel source of immune modulatory compounds for the treatment of type 1 diabetes, which afflicts more than 2 million individuals in Europe and North America.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/4-Butyrolactone,
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Dimethyl Sulfoxide,
http://linkedlifedata.com/resource/pubmed/chemical/Homoserine,
http://linkedlifedata.com/resource/pubmed/chemical/N-(3-oxododecanoyl)homoserine...,
http://linkedlifedata.com/resource/pubmed/chemical/N-(3-oxohexanoyl)-3-aminodihydro-2(3...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0940-5429
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16258734-4-Butyrolactone,
pubmed-meshheading:16258734-Adjuvants, Immunologic,
pubmed-meshheading:16258734-Animals,
pubmed-meshheading:16258734-Diabetes Mellitus,
pubmed-meshheading:16258734-Dimethyl Sulfoxide,
pubmed-meshheading:16258734-Disease Models, Animal,
pubmed-meshheading:16258734-Homoserine,
pubmed-meshheading:16258734-Inflammation,
pubmed-meshheading:16258734-Islets of Langerhans,
pubmed-meshheading:16258734-Mice,
pubmed-meshheading:16258734-Mice, Inbred NOD,
pubmed-meshheading:16258734-Pancreatic Diseases,
pubmed-meshheading:16258734-Pseudomonas aeruginosa
|
pubmed:year |
2005
|
pubmed:articleTitle |
Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosa signal molecule, N-(3-oxododecanoyl)-L-homoserine lactone.
|
pubmed:affiliation |
School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK. pazdp@gwmail.nottingham.ac.uk
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|